Singapore markets open in 1 hour 1 minute
  • Straits Times Index

    3,201.89
    +10.73 (+0.34%)
     
  • S&P 500

    4,088.85
    +80.84 (+2.02%)
     
  • Dow

    32,654.59
    +431.17 (+1.34%)
     
  • Nasdaq

    11,984.52
    +321.73 (+2.76%)
     
  • BTC-USD

    30,425.69
    +546.98 (+1.83%)
     
  • CMC Crypto 200

    677.94
    +435.26 (+179.36%)
     
  • FTSE 100

    7,518.35
    +53.55 (+0.72%)
     
  • Gold

    1,812.00
    -6.90 (-0.38%)
     
  • Crude Oil

    113.68
    +1.28 (+1.14%)
     
  • 10-Yr Bond

    2.9680
    +0.0910 (+3.16%)
     
  • Nikkei

    26,659.75
    +112.70 (+0.42%)
     
  • Hang Seng

    20,602.52
    +652.31 (+3.27%)
     
  • FTSE Bursa Malaysia

    1,548.60
    +4.19 (+0.27%)
     
  • Jakarta Composite Index

    6,644.47
    +46.47 (+0.70%)
     
  • PSE Index

    6,594.66
    +92.54 (+1.42%)
     

Where Will Cassava Sciences Be in 1 Year?

·5-min read
Where Will Cassava Sciences Be in 1 Year?
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

First, the company produced strong results in clinical studies for its potential therapy for Alzheimer's disease (AD), Simufilam. The other reason is the result of Biogen, a competitor, receiving regulatory approval in the U.S. last year for its novel AD treatment -- the first such therapy approved for AD since 2003.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting